Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age-and serotype-dependent incidence of invasive …

J Picazo, J Ruiz-Contreras… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
ABSTRACT In Madrid, Spain, the 13-valent pneumococcal conjugate vaccine (PCV13)
replaced PCV7 in the pediatric universal vaccination calendar in June 2010. A prospective …

Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in …

J Picazo, J Ruiz-Contreras… - The Pediatric …, 2013 - journals.lww.com
Background: Differences in invasive pneumococcal disease (IPD) in children are expected
after a change from 7-valent pneumococcal conjugate vaccine (PCV7) to 13-valent …

Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal …

J Picazo, J Ruiz-Contreras… - Clinical and Vaccine …, 2011 - Am Soc Microbiol
To assess invasive pneumococcal disease (IPD) clinical presentations and relationships
with age and serotype in hospitalized children (< 15 years) after PCV7 implementation in …

Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The …

JJ Picazo, J Ruiz-Contreras, J Casado-Flores… - Vaccine, 2019 - Elsevier
Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide. Using the
data from the HERACLES clinical surveillance study (2007–2016), we describe the …

[HTML][HTML] Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in …

A González-Díaz, J Càmara, M Ercibengoa… - Clinical Microbiology …, 2020 - Elsevier
Objective An early reduction of adult invasive pneumococcal disease (IPD) was observed
after the 13-valent pneumococcal conjugate vaccine (PCV13) introduction for children in …

Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction …

C Ardanuy, F Tubau, R Pallares… - Clinical Infectious …, 2009 - academic.oup.com
Background. A dramatic decrease in the incidence of invasive pneumococcal disease (IPD)
was observed among children and adults in the United States after the introduction of the 7 …

[HTML][HTML] Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based …

J Picazo, J Ruiz-Contreras, J Casado-Flores… - PLoS …, 2017 - journals.plos.org
In the Community of Madrid, the 13-valent pneumococcal conjugate vaccine (PCV13)
replaced the 7-valent (PCV7) in the fully government-funded Regional Immunization …

Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine

C Munoz-Almagro, I Jordan, A Gene… - Clinical Infectious …, 2008 - academic.oup.com
Background. Little is known about the epidemiology of invasive pneumococcal disease
(IPD) after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7) in Spain …

[HTML][HTML] Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain

J Càmara, JM Marimón, E Cercenado, N Larrosa… - PLoS …, 2017 - journals.plos.org
A prospective laboratory-based multicenter study that collected all adult invasive
pneumococcal disease (IPD) episodes from 6 Spanish hospitals before (2008–2009) and …

Rapid decrease in rates of hospitalization resulting from invasive pneumococcal disease and community-acquired pneumonia in children aged< 60 months after 13 …

EL López, E Glatstein, GC Ezcurra… - Journal of the …, 2018 - academic.oup.com
Abstract Background In January 2012, Argentina included universal pneumococcal
vaccination in the routine childhood vaccination program using a 13-valent pneumococcal …